Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 26, 2026International Journal of Gynecological Pathology

SOX2 Can Support a Diagnosis of PiMHEC With Rare to Absent Ghost Cells and Can Distinguish PiMHEC From Its Most Problematic Mimickers

View Full Paper
Ask AI
Bookmark
Share

Authors

JXJin XuPWPaul Weisman

Discussion

Loading...

Member takes

Overview

Randomized trial evaluated SOX2 to confirm PiMHEC diagnosis, indicating its significance against mimickers.

Key Points

  • This research aims to assess SOX2 immunohistochemistry as a diagnostic tool for pilomatrix-like high-grade endometrioid carcinoma (PiMHEC).
  • Evaluated SOX2 expression in 26 cases of PiMHEC and problematic mimickers.
  • Analyzed non-PiMHEC FIGO grade 3 endometrioid carcinomas with aberrant beta-catenin and undifferentiated/dedifferentiated EMCA.
  • Employing a tissue microarray with 84 endometrioid carcinoma cases for comparison.
  • All 26 PiMHEC cases showed robust SOX2 positivity, confirming its diagnostic value.
  • None of the non-PiMHEC FIGO grade 3 EMCAs with aberrant beta-catenin expressed SOX2.
  • Only 5 of 84 EMCA cases exhibited SOX2 positivity, indicating that SOX2 effectively distinguishes PiMHEC from mimickers.

Cite This Study

Xu et al. (2026) studied this question.

synapsesocial.com/papers/6a65a9f3d3aea3239cd794bdhttps://doi.org/10.1097/pgp.0000000000001197
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1SOX2 Is the Most Sensitive Biomarker in Testicular and Gynecologic Embryonic-type Neuroectodermal Tumors (ENT) Based on a Comprehensive Evaluation of Biomarker Expression2025
  2. 2A 5‐marker immunohistochemical panel of <scp>CK17</scp>, <scp>MEP1A</scp>, <scp>PAX8</scp>, <scp>SMAD4</scp>, and <scp>CDX2</scp> to distinguish ovarian mucinous carcinoma from metastatic pancreatic ductal adenocarcinoma2025
  3. 3Assessment of SOX2 performance as a marker for circulating cancer stem-like cells (CCSCs) identification in advanced breast cancer patients using CytoTrack system2025
  4. 4The role of SOX-10 in identifying nodal metastasis in canine malignant melanoma.2025
  5. 5Abnormal Nuclear Membranous Staining Pattern by MLH1 Immunohistochemistry in Endometrial Cancer: A Diagnostic Pitfall and Clone-dependent Artifact2025